BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32418154)

  • 21. Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.
    Quintanar T; Font C; Gallardo E; Barba R; Obispo B; Díaz-Pedroche C
    Clin Transl Oncol; 2021 Apr; 23(4):697-708. PubMed ID: 32885400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
    J Clin Oncol; 2017 May; 35(13):1453-1486. PubMed ID: 28165299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidisciplinary consensus on cancer management during pregnancy.
    Cubillo A; Morales S; Goñi E; Matute F; Muñoz JL; Pérez-Díaz D; de Santiago J; Rodríguez-Lescure Á
    Clin Transl Oncol; 2021 Jun; 23(6):1054-1066. PubMed ID: 33191439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of
    Bourhis A; De Luca C; Cariou M; Vigliar E; Barel F; Conticelli F; Marcorelles P; Nousbaum JB; Robaszkiewicz M; Samaison L; Badic B; Doucet L; Troncone G; Uguen A
    J Clin Pathol; 2020 Nov; 73(11):741-747. PubMed ID: 32273401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].
    Matías-Guiu X; Fusté V; Iglesias L; Balañá C; Concha Á; de la Cruz-Merino L; Nieto B; Pané M; Sanz J; Losa F
    Rev Esp Patol; 2019; 52(1):33-44. PubMed ID: 30583830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.
    Vera R; González-Flores E; Rubio C; Urbano J; Valero Camps M; Ciampi-Dopazo JJ; Orcajo Rincón J; Morillo Macías V; Gomez Braco MA; Suarez-Artacho G
    Clin Transl Oncol; 2020 May; 22(5):647-662. PubMed ID: 31359336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    Franczak C; Dubouis L; Gilson P; Husson M; Rouyer M; Demange J; Leroux A; Merlin JL; Harlé A
    PLoS One; 2019; 14(2):e0212801. PubMed ID: 30811471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.
    García-Carbonero R; Vera R; Rivera F; Parlorio E; Pagés M; González-Flores E; Fernández-Martos C; Corral MÁ; Bouzas R; Matute F
    Clin Transl Oncol; 2017 Feb; 19(2):135-148. PubMed ID: 27206566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus document on the implementation of next generation sequencing in the genetic diagnosis of hereditary cancer.
    Soto JL; Blanco I; Díez O; García Planells J; Lorda I; Matthijs G; Robledo M; Souche E; Lázaro C
    Med Clin (Barc); 2018 Jul; 151(2):80.e1-80.e10. PubMed ID: 29439875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.
    Armengol G; Sarhadi VK; Ghanbari R; Doghaei-Moghaddam M; Ansari R; Sotoudeh M; Puolakkainen P; Kokkola A; Malekzadeh R; Knuutila S
    J Mol Diagn; 2016 Jul; 18(4):471-9. PubMed ID: 27155048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours].
    Rojo F; Colomer R; López-Ríos F; Bautista F; Álvarez R; de Álava E; Hladun R; Garrido P
    Rev Esp Patol; 2021; 54(4):250-262. PubMed ID: 34544555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain.
    Rodríguez-Lescure A; de la Peña FA; Aranda E; Calvo A; Felip E; Garrido P; Vera R
    Clin Transl Oncol; 2020 Dec; 22(12):2253-2263. PubMed ID: 32533318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study.
    Henao F; Manzano A; Lopez Lopez R; Gobartt AL; de Las Peñas R
    Adv Ther; 2021 Jan; 38(1):290-303. PubMed ID: 33111255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
    Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Bryan Rumble R; Temple-Smolkin R; B Ventura C; Nowak JA
    Arch Pathol Lab Med; 2017 May; 141(5):625-657. PubMed ID: 28165284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
    Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
    J Mol Diagn; 2017 Mar; 19(2):187-225. PubMed ID: 28185757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP.
    Fernández-Esparrach G; Marín-Gabriel JC; Díez Redondo P; Núñez H; Rodríguez de Santiago E; Rosón P; Calvet X; Cuatrecasas M; Cubiella J; Moreira L; Pardo López ML; Pérez Aisa Á; Sanz Anquela JM;
    Gastroenterol Hepatol; 2021; 44(6):448-464. PubMed ID: 33609597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology.
    Picó A; Aranda-López I; Sesmilo G; Toldos-González Ó; Japón MA; Luque RM; Puig-Domingo M
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Mar; 68(3):196-207. PubMed ID: 34167699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.